Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.

Abstract excerpt

Many of the mutations associated with Duchenne muscular dystrophy can potentially be rescued by exon-skipping therapy, targeting selected exons of prespliced mRNA for the dystrophin gene with antisense oligonucleotides, thereby restoring reading frames. The recent development of antisense oligonucleotides with higher stability and lower toxicity, such as morpholinos, has made it possible to restore dystrophin...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Design
• Share to Dystrophin
• Share to Gene Targeting